PET/CT scan test to see lung cancer using a new tracer
Part of Cancer, Lungs & breathing clinical trials.
This early-phase study tests a special whole-body scan (PET/CT) that uses injected tracers to help show where lung cancer may be. It may help researchers see tumors more clearly and compare different tracers during the same time window.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed or suspected lung cancer
- You can have a PET/CT scan using 68Ga-FAPI-RGD within 2 weeks (and possibly another tracer like 18F-FDG, 68Ga-FAPI, or 68Ga-RGD)
- You are able to sign informed consent (a written agreement to join)
- You are not pregnant
- You are not breastfeeding
- Your medical condition should not be expected to interfere with safely completing the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at using a specific PET/CT scan (a whole-body imaging test) to help evaluate cancer that is confirmed or suspected. If you are eligible, you may receive this scan soon after a recent FDG PET/CT to compare or improve how cancers are identified.
This early-phase study tests special PET/CT scans using a radioactive tracer to see cancer areas that have specific targets. It may help doctors better visualize tumors and plan next steps, using scans that you may already be familiar with (FDG) plus targeted tracers.
This early (Phase 1) study compares two types of PET-CT scans to see how well they detect and measure lung scarring (pulmonary fibrosis). It may help doctors choose the best scan test for diagnosis in the future.
This trial studies how well a specific PET/CT scan using a radioactive tracer can detect or evaluate cancers. It may help doctors see where cancer is in the body more clearly.
This trial tests a new type of imaging scan that uses a special tracer to help doctors see solid tumors more clearly. The scan may help improve how tumors are detected and monitored during treatment.
This trial tests a new type of imaging scan and treatment for cancers that have spread. You would first have two special scans, then you may receive a targeted radiation therapy (177Lu-FAPI-RGD) to see if it can help shrink tumors.
Hear when a new Lung Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.